Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA Methylation in Nonalcoholic Fatty Liver Disease
Jeongeun Hyun, Youngmi Jung
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8138-8138
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
Oriol Juanola, Sebastián Martínez‐López, Rubén Francés, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 10, pp. 5227-5227
Open Access | Times Cited: 204
Epigenetics of Aging and Aging-Associated Diseases
Dominik Saul, Robyn Laura Kosinsky
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 401-401
Open Access | Times Cited: 171
Current Options and Future Directions for NAFLD and NASH Treatment
Chunye Zhang, Ming Yang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7571-7571
Open Access | Times Cited: 76
Epigenetic regulation of energy metabolism in obesity
Wei Gao, Jiali Liu, Xiang Lü, et al.
Journal of Molecular Cell Biology (2021) Vol. 13, Iss. 7, pp. 480-499
Open Access | Times Cited: 60
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou, Marinos Pericleous, Irena Stefanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 49
Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach
Daniela Stols‐Gonçalves, Anne Linde Mak, Mette Simone Aae Madsen, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation
Shirong Wang, Lin Zha, Xin Cui, et al.
Advanced Science (2023) Vol. 10, Iss. 20
Open Access | Times Cited: 32
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 32
Role of ammonia in NAFLD: An unusual suspect
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein Kerbert, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100780-100780
Open Access | Times Cited: 26
Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatment
Yijing Li, Lijie Li, Yishuo Zhang, et al.
Therapeutic Advances in Endocrinology and Metabolism (2025) Vol. 16
Open Access | Times Cited: 1
An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
Jonathan S. Rodríguez-Sanabria, Rebeca Escutia-Gutiérrez, Rebeca Rosas-Campos, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 32
Detangling the interrelations between MAFLD, insulin resistance, and key hormones
Shreya C. Pal, Mohammed Eslam, Nahúm Méndez‐Sánchez
HORMONES (2022) Vol. 21, Iss. 4, pp. 573-589
Closed Access | Times Cited: 30
DNA 5mC and RNA m6A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression
Yue Feng, Shihui Guo, Yulan Zhao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1211-1220
Closed Access | Times Cited: 20
Synergistic Differential DNA Demethylation Activity of Danshensu (Salvia miltiorrhiza) Associated with Different Probiotics in Nonalcoholic Fatty Liver Disease
Amr Hassan, Patrícia Rijo, Tamer M. M. Abu-Amara, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 279-279
Open Access | Times Cited: 7
Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD
Nicholas D. Johnson, Xiumei Wu, Christopher D. Still, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease
Tahar Hajri, Mohamed Zaiou, Thomas V. Fungwe, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1355-1355
Open Access | Times Cited: 35
Extending human healthspan and longevity: a symposium report
Loren M. DeVito, Nir Barzilai, Ana María Cuervo, et al.
Annals of the New York Academy of Sciences (2021) Vol. 1507, Iss. 1, pp. 70-83
Open Access | Times Cited: 34
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
Aamir Bashir, Ajay Duseja, Arka De, et al.
Liver Research (2022) Vol. 6, Iss. 2, pp. 72-83
Open Access | Times Cited: 23
Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis
Jangho Lee, Ji‐Hye Song, Jae‐Ho Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 143-157
Open Access | Times Cited: 14
AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD
Ling Wen, Minyan Li, Xiaojun Lin, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 21
Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1α
Lu Xu, Zhe Huang, Tak-Ho Lo, et al.
Theranostics (2022) Vol. 12, Iss. 6, pp. 2502-2518
Open Access | Times Cited: 20
Deciphering the role of aberrant DNA methylation in NAFLD and NASH
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e11119-e11119
Open Access | Times Cited: 20
Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease
Ni Zhang, Xinchen Tian, Tinghao Yan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154809-154809
Closed Access | Times Cited: 13
Liver saturated fat content associates with hepatic DNA methylation in obese individuals
Ratika Sehgal, Alexander Perfilyev, Ville Männistö, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top